Search results for: 'prenatal test'

The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient to drive the overall recovery of the region. As companies continue to focus o...

This study provides an insight into the US market for bacteriological test kits for meat and dairy applications in 2016. Drivers, restraints, competitive landscape, and market trends are discussed. The market is segmented by the end applications of meat production and dairy production and covers cultivation test kits, immunoassay test kits, polymer...

The report offers a detailed strategic assessment of outsourced non-destructive testing (NDT) services across Saudi Arabia, the UAE, Kuwait, and Bahrain. As infrastructure projects, offshore developments, and plant maintenance programs expand across the region, the demand for advanced inspection services is growing rapidly. This study focuses exclu...

In 2024, regional conflicts significantly disrupted global supply chains, drove up commodity prices, and undermined political stability. These challenges are expected to persist in 2025, further exacerbating economic uncertainty. Market instability will become a key concern as businesses and governments struggle to navigate an increasingly unpredic...

COVID-19 brought about major changes for companies and industries globally, followed by a recovery of operations in 2021. 2022 began with the war between Russia and Ukraine, which created fears of a global recession and inflation, resulting in uncertainties among manufacturers to plan future investments. While Europe is likely to be affected more, ...

The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized treatment, and expanded access to testing across h...

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

Sustainability has emerged as a crucial focus for businesses, extending beyond a buzzword to become a vital component of corporate strategy. This significance is evident among test and measurement (T&M) companies, which are actively committed to achieving the United Nations’ Sustainable Development Goals (SDGs) adopted in 2015. The UN has establish...

As COVID-19 transitions to the endemic phase, automation solutions and smart, connected laboratories will catalyze recovery in the next-generation diagnostics industry. The COVID-19 pandemic left a lot of installed capacity in laboratories and healthcare centers. To take advantage of this situation, it is necessary for industry players to focus on ...